The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo.
A legfontosabb adatok
- Ki végzi
- Cairo University
- Hol
- Cairo (Egyiptom)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Fázis
- 4. fázis
- Résztvevők
- 60 fő, tervezett
- Kezdés
- 2026. márc. 15.
- Tervezett befejezés
- 2026. júl. 1.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Non-cultured epidermal cell suspension (NCES) surgery
- Oral mini pulse
- Excimer Sessions
- A regiszteradat frissítve
- 2026. március 16.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for people with stable segmental or non-acral vitiligo who will have NCES skin cell surgery. It tests whether adding low-dose oral dexamethasone helps the results.
- Életkor
- 12 years and older.
- Nem
- All sexes can join.
- A betegség stádiuma
- Segmental vitiligo, or non-acral vitiligo (not on hands and feet) on areas like the face and trunk. Patches have not responded to usual treatment. Vitiligo has been stable for 1 year or more.
- Korábbi kezelés
- No systemic or topical treatment for at least 3 months before joining. Usual treatment has not worked.
A részvétel fő kizáró okai
- Acral vitiligo (on hands and feet), or patches on knees and elbows.
- Active vitiligo: new or growing patches, or other signs of activity in less than 1 year.
- Pregnant women.
- Reasons not to take steroids, like uncontrolled high blood pressure, diabetes or tuberculosis.
- Systemic or topical treatment in the past 3 months.
A regiszter feltételei, szó szerint
Mind a 13 feltétel megnézéseKevesebb
Ki vehet részt
- Patients with segmental vitiligo lesions that are not responsive to conventional treatment
- Patients with non-Acral vitiligo lesions that are not responsive to conventional treatment and on sites known to be responsive to surgery, like the face and trunk
- Stability for ≥ 1 year
- Age ≥12 years
- Lack of systemic and topical treatment for at least 3 months prior inclusion in the study
Ki nem vehet részt
- Non acral vitiligo lesions on sites that are knowingly not responsive to surgery, like knees and elbows
- Active vitiligo; new lesions, expansion of old lesions, confetti like lesions, ill-defined edges, hypochromia, depigmentation of previously pigmented areas or koebnerization in < 1 year
- Patients with contraindication to systemic steroid like uncontrolled hypertension, diabetes or tuberculosis
- Age < 12 years
- Acral vitiligo
- Segmental vitiligo lesions that are responsive to conventional treatment
- Pregnant females
- Systemic and topical treatment in the past 3 months
Helyszínek itt: Egyiptom
- Dermatology out patient clinic, Faculty of Medicine, Cairo UniversityCairo, EgyiptomContact: Lobna Alieldin, Lecturer of DermatologyToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to learn if adding mini-oral pulse steroid therapy improves the results of non-cultured epidermal cell suspension (NCES) surgery in patients with stable vitiligo. It will also evaluate the safety of this treatment approach. The main questions it aims to answer are:
A teljes eredeti leírásKevesebb
* Does adding mini-oral pulse steroid therapy reduce the development of a perilesional halo after NCES surgery? * Does the addition of steroids improve the degree of repigmentation and overall treatment outcomes in vitiligo lesions?
Researchers will compare NCES surgery with mini-oral pulse steroids to NCES surgery alone to determine whether the steroid therapy improves surgical outcomes.
Participants will:
* Undergo NCES vitiligo surgery for stable segmental or non-acral vitiligo lesions. * Be randomly assigned to receive either surgery alone or surgery plus low-dose oral mini-pulse dexamethasone therapy. * Attend follow-up visits and clinical assessments for approximately 4 months. * Receive excimer laser sessions twice weekly after healing and have standardized photographs and scoring assessments to evaluate repigmentation.
A vizsgálat 2 csoportja
- Non-cultured epidermal cell suspension surgery with Mini-Oral Pulse Steroid TherapyMár használt kezelés, összehasonlításként
Participants will receive low-dose oral mini-pulse dexamethasone (5 mg/week given on two consecutive days) for 4 weeks before and 4 weeks after undergoing non-cultured epidermal cell suspension (NCES) surgery for stable vitiligo lesions. After healing, participants will receive excimer laser sessions twice weekly and will be followed for 4 months to assess repigmentation, development of perilesional halo, and treatment safety.
Kezelés: Non-cultured epidermal cell suspension (NCES) surgery, Oral mini pulse és Excimer Sessions
- Non-cultured epidermal cell suspension Surgery AloneEgyéb csoport
Participants will undergo non-cultured epidermal cell suspension (NCES) surgery for stable vitiligo lesions without oral mini-pulse steroid therapy. After healing, participants will receive excimer laser sessions twice weekly and will be followed for 4 months to evaluate repigmentation outcomes and development of perilesional halo.
Kezelés: Non-cultured epidermal cell suspension (NCES) surgery és Excimer Sessions
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo: An Interventional Prospective Randomized Controlled Trial.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. március 16.